Zeigen die neuen oralen Therapien Vorteile in der Basistherapie der Multiplen Sklerose? Pro
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605452970 | ||
| 003 | CHVBK | ||
| 005 | 20210128100159.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20150401xx s 000 0 ger | ||
| 024 | 7 | 0 | |a 10.1007/s00115-014-4243-z |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s00115-014-4243-z | ||
| 100 | 1 | |a Meuth |D S.G. |u Klinik für Neurologie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Deutschland |4 aut | |
| 245 | 1 | 0 | |a Zeigen die neuen oralen Therapien Vorteile in der Basistherapie der Multiplen Sklerose? Pro |h [Elektronische Daten] |c [S.G. Meuth] |
| 246 | 0 | |a Do new oral therapies show advantages in the basal therapy of multiple sclerosis? Pro | |
| 540 | |a Springer-Verlag Berlin Heidelberg, 2015 | ||
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00115-014-4243-z |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a research-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s00115-014-4243-z |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 100 |E 1- |a Meuth |D S.G. |u Klinik für Neurologie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Deutschland |4 aut | ||